Request for Covid-19 Impact Assessment of this Report
The United States Direct Oral Anticoagulant market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Direct Oral Anticoagulant market, reaching US$ million by the year 2028. As for the Europe Direct Oral Anticoagulant landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Direct Oral Anticoagulant players cover Bristol-Meyers Squibb Co, Pfizer Inc., Boehringer Ingelheim Pharmaceuticals, Inc, and Janssen Pharmaceuticals, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Direct Oral Anticoagulant market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Apixaban
Dabigatran
Rivaroxaban
Edoxaban
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals Pharmacies
Drug Stores
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bristol-Meyers Squibb Co
Pfizer Inc.
Boehringer Ingelheim Pharmaceuticals, Inc
Janssen Pharmaceuticals, Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd
Pab Organics Private Limited
Daiichi Sankyo Company, Limited
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Direct Oral Anticoagulant Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Direct Oral Anticoagulant by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Direct Oral Anticoagulant by Country/Region, 2017, 2022 & 2028
2.2 Direct Oral Anticoagulant Segment by Type
2.2.1 Apixaban
2.2.2 Dabigatran
2.2.3 Rivaroxaban
2.2.4 Edoxaban
2.3 Direct Oral Anticoagulant Sales by Type
2.3.1 Global Direct Oral Anticoagulant Sales Market Share by Type (2017-2022)
2.3.2 Global Direct Oral Anticoagulant Revenue and Market Share by Type (2017-2022)
2.3.3 Global Direct Oral Anticoagulant Sale Price by Type (2017-2022)
2.4 Direct Oral Anticoagulant Segment by Application
2.4.1 Hospitals Pharmacies
2.4.2 Drug Stores
2.4.3 Online Pharmacies
2.5 Direct Oral Anticoagulant Sales by Application
2.5.1 Global Direct Oral Anticoagulant Sale Market Share by Application (2017-2022)
2.5.2 Global Direct Oral Anticoagulant Revenue and Market Share by Application (2017-2022)
2.5.3 Global Direct Oral Anticoagulant Sale Price by Application (2017-2022)
3 Global Direct Oral Anticoagulant by Company
3.1 Global Direct Oral Anticoagulant Breakdown Data by Company
3.1.1 Global Direct Oral Anticoagulant Annual Sales by Company (2020-2022)
3.1.2 Global Direct Oral Anticoagulant Sales Market Share by Company (2020-2022)
3.2 Global Direct Oral Anticoagulant Annual Revenue by Company (2020-2022)
3.2.1 Global Direct Oral Anticoagulant Revenue by Company (2020-2022)
3.2.2 Global Direct Oral Anticoagulant Revenue Market Share by Company (2020-2022)
3.3 Global Direct Oral Anticoagulant Sale Price by Company
3.4 Key Manufacturers Direct Oral Anticoagulant Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Direct Oral Anticoagulant Product Location Distribution
3.4.2 Players Direct Oral Anticoagulant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Direct Oral Anticoagulant by Geographic Region
4.1 World Historic Direct Oral Anticoagulant Market Size by Geographic Region (2017-2022)
4.1.1 Global Direct Oral Anticoagulant Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Direct Oral Anticoagulant Annual Revenue by Geographic Region
4.2 World Historic Direct Oral Anticoagulant Market Size by Country/Region (2017-2022)
4.2.1 Global Direct Oral Anticoagulant Annual Sales by Country/Region (2017-2022)
4.2.2 Global Direct Oral Anticoagulant Annual Revenue by Country/Region
4.3 Americas Direct Oral Anticoagulant Sales Growth
4.4 APAC Direct Oral Anticoagulant Sales Growth
4.5 Europe Direct Oral Anticoagulant Sales Growth
4.6 Middle East & Africa Direct Oral Anticoagulant Sales Growth
5 Americas
5.1 Americas Direct Oral Anticoagulant Sales by Country
5.1.1 Americas Direct Oral Anticoagulant Sales by Country (2017-2022)
5.1.2 Americas Direct Oral Anticoagulant Revenue by Country (2017-2022)
5.2 Americas Direct Oral Anticoagulant Sales by Type
5.3 Americas Direct Oral Anticoagulant Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Direct Oral Anticoagulant Sales by Region
6.1.1 APAC Direct Oral Anticoagulant Sales by Region (2017-2022)
6.1.2 APAC Direct Oral Anticoagulant Revenue by Region (2017-2022)
6.2 APAC Direct Oral Anticoagulant Sales by Type
6.3 APAC Direct Oral Anticoagulant Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Direct Oral Anticoagulant by Country
7.1.1 Europe Direct Oral Anticoagulant Sales by Country (2017-2022)
7.1.2 Europe Direct Oral Anticoagulant Revenue by Country (2017-2022)
7.2 Europe Direct Oral Anticoagulant Sales by Type
7.3 Europe Direct Oral Anticoagulant Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Direct Oral Anticoagulant by Country
8.1.1 Middle East & Africa Direct Oral Anticoagulant Sales by Country (2017-2022)
8.1.2 Middle East & Africa Direct Oral Anticoagulant Revenue by Country (2017-2022)
8.2 Middle East & Africa Direct Oral Anticoagulant Sales by Type
8.3 Middle East & Africa Direct Oral Anticoagulant Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Direct Oral Anticoagulant
10.3 Manufacturing Process Analysis of Direct Oral Anticoagulant
10.4 Industry Chain Structure of Direct Oral Anticoagulant
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Direct Oral Anticoagulant Distributors
11.3 Direct Oral Anticoagulant Customer
12 World Forecast Review for Direct Oral Anticoagulant by Geographic Region
12.1 Global Direct Oral Anticoagulant Market Size Forecast by Region
12.1.1 Global Direct Oral Anticoagulant Forecast by Region (2023-2028)
12.1.2 Global Direct Oral Anticoagulant Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Direct Oral Anticoagulant Forecast by Type
12.7 Global Direct Oral Anticoagulant Forecast by Application
13 Key Players Analysis
13.1 Bristol-Meyers Squibb Co
13.1.1 Bristol-Meyers Squibb Co Company Information
13.1.2 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product Offered
13.1.3 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bristol-Meyers Squibb Co Main Business Overview
13.1.5 Bristol-Meyers Squibb Co Latest Developments
13.2 Pfizer Inc.
13.2.1 Pfizer Inc. Company Information
13.2.2 Pfizer Inc. Direct Oral Anticoagulant Product Offered
13.2.3 Pfizer Inc. Direct Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Pfizer Inc. Main Business Overview
13.2.5 Pfizer Inc. Latest Developments
13.3 Boehringer Ingelheim Pharmaceuticals, Inc
13.3.1 Boehringer Ingelheim Pharmaceuticals, Inc Company Information
13.3.2 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product Offered
13.3.3 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Boehringer Ingelheim Pharmaceuticals, Inc Main Business Overview
13.3.5 Boehringer Ingelheim Pharmaceuticals, Inc Latest Developments
13.4 Janssen Pharmaceuticals, Inc.
13.4.1 Janssen Pharmaceuticals, Inc. Company Information
13.4.2 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product Offered
13.4.3 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Janssen Pharmaceuticals, Inc. Main Business Overview
13.4.5 Janssen Pharmaceuticals, Inc. Latest Developments
13.5 Bayer AG
13.5.1 Bayer AG Company Information
13.5.2 Bayer AG Direct Oral Anticoagulant Product Offered
13.5.3 Bayer AG Direct Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bayer AG Main Business Overview
13.5.5 Bayer AG Latest Developments
13.6 Teva Pharmaceutical Industries Ltd
13.6.1 Teva Pharmaceutical Industries Ltd Company Information
13.6.2 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product Offered
13.6.3 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.6.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.7 Pab Organics Private Limited
13.7.1 Pab Organics Private Limited Company Information
13.7.2 Pab Organics Private Limited Direct Oral Anticoagulant Product Offered
13.7.3 Pab Organics Private Limited Direct Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Pab Organics Private Limited Main Business Overview
13.7.5 Pab Organics Private Limited Latest Developments
13.8 Daiichi Sankyo Company, Limited
13.8.1 Daiichi Sankyo Company, Limited Company Information
13.8.2 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product Offered
13.8.3 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Daiichi Sankyo Company, Limited Main Business Overview
13.8.5 Daiichi Sankyo Company, Limited Latest Developments
14 Research Findings and Conclusion
Table 1. Direct Oral Anticoagulant Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Direct Oral Anticoagulant Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Apixaban
Table 4. Major Players of Dabigatran
Table 5. Major Players of Rivaroxaban
Table 6. Major Players of Edoxaban
Table 7. Global Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT)
Table 8. Global Direct Oral Anticoagulant Sales Market Share by Type (2017-2022)
Table 9. Global Direct Oral Anticoagulant Revenue by Type (2017-2022) & ($ million)
Table 10. Global Direct Oral Anticoagulant Revenue Market Share by Type (2017-2022)
Table 11. Global Direct Oral Anticoagulant Sale Price by Type (2017-2022) & (USD/Kg)
Table 12. Global Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT)
Table 13. Global Direct Oral Anticoagulant Sales Market Share by Application (2017-2022)
Table 14. Global Direct Oral Anticoagulant Revenue by Application (2017-2022)
Table 15. Global Direct Oral Anticoagulant Revenue Market Share by Application (2017-2022)
Table 16. Global Direct Oral Anticoagulant Sale Price by Application (2017-2022) & (USD/Kg)
Table 17. Global Direct Oral Anticoagulant Sales by Company (2020-2022) & (MT)
Table 18. Global Direct Oral Anticoagulant Sales Market Share by Company (2020-2022)
Table 19. Global Direct Oral Anticoagulant Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Direct Oral Anticoagulant Revenue Market Share by Company (2020-2022)
Table 21. Global Direct Oral Anticoagulant Sale Price by Company (2020-2022) & (USD/Kg)
Table 22. Key Manufacturers Direct Oral Anticoagulant Producing Area Distribution and Sales Area
Table 23. Players Direct Oral Anticoagulant Products Offered
Table 24. Direct Oral Anticoagulant Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Direct Oral Anticoagulant Sales by Geographic Region (2017-2022) & (MT)
Table 28. Global Direct Oral Anticoagulant Sales Market Share Geographic Region (2017-2022)
Table 29. Global Direct Oral Anticoagulant Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Direct Oral Anticoagulant Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Direct Oral Anticoagulant Sales by Country/Region (2017-2022) & (MT)
Table 32. Global Direct Oral Anticoagulant Sales Market Share by Country/Region (2017-2022)
Table 33. Global Direct Oral Anticoagulant Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Direct Oral Anticoagulant Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Direct Oral Anticoagulant Sales by Country (2017-2022) & (MT)
Table 36. Americas Direct Oral Anticoagulant Sales Market Share by Country (2017-2022)
Table 37. Americas Direct Oral Anticoagulant Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Direct Oral Anticoagulant Revenue Market Share by Country (2017-2022)
Table 39. Americas Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT)
Table 40. Americas Direct Oral Anticoagulant Sales Market Share by Type (2017-2022)
Table 41. Americas Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT)
Table 42. Americas Direct Oral Anticoagulant Sales Market Share by Application (2017-2022)
Table 43. APAC Direct Oral Anticoagulant Sales by Region (2017-2022) & (MT)
Table 44. APAC Direct Oral Anticoagulant Sales Market Share by Region (2017-2022)
Table 45. APAC Direct Oral Anticoagulant Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Direct Oral Anticoagulant Revenue Market Share by Region (2017-2022)
Table 47. APAC Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT)
Table 48. APAC Direct Oral Anticoagulant Sales Market Share by Type (2017-2022)
Table 49. APAC Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT)
Table 50. APAC Direct Oral Anticoagulant Sales Market Share by Application (2017-2022)
Table 51. Europe Direct Oral Anticoagulant Sales by Country (2017-2022) & (MT)
Table 52. Europe Direct Oral Anticoagulant Sales Market Share by Country (2017-2022)
Table 53. Europe Direct Oral Anticoagulant Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Direct Oral Anticoagulant Revenue Market Share by Country (2017-2022)
Table 55. Europe Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT)
Table 56. Europe Direct Oral Anticoagulant Sales Market Share by Type (2017-2022)
Table 57. Europe Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT)
Table 58. Europe Direct Oral Anticoagulant Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Direct Oral Anticoagulant Sales by Country (2017-2022) & (MT)
Table 60. Middle East & Africa Direct Oral Anticoagulant Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Direct Oral Anticoagulant Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Direct Oral Anticoagulant Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Direct Oral Anticoagulant Sales by Type (2017-2022) & (MT)
Table 64. Middle East & Africa Direct Oral Anticoagulant Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Direct Oral Anticoagulant Sales by Application (2017-2022) & (MT)
Table 66. Middle East & Africa Direct Oral Anticoagulant Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Direct Oral Anticoagulant
Table 68. Key Market Challenges & Risks of Direct Oral Anticoagulant
Table 69. Key Industry Trends of Direct Oral Anticoagulant
Table 70. Direct Oral Anticoagulant Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Direct Oral Anticoagulant Distributors List
Table 73. Direct Oral Anticoagulant Customer List
Table 74. Global Direct Oral Anticoagulant Sales Forecast by Region (2023-2028) & (MT)
Table 75. Global Direct Oral Anticoagulant Sales Market Forecast by Region
Table 76. Global Direct Oral Anticoagulant Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Direct Oral Anticoagulant Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Direct Oral Anticoagulant Sales Forecast by Country (2023-2028) & (MT)
Table 79. Americas Direct Oral Anticoagulant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Direct Oral Anticoagulant Sales Forecast by Region (2023-2028) & (MT)
Table 81. APAC Direct Oral Anticoagulant Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Direct Oral Anticoagulant Sales Forecast by Country (2023-2028) & (MT)
Table 83. Europe Direct Oral Anticoagulant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Direct Oral Anticoagulant Sales Forecast by Country (2023-2028) & (MT)
Table 85. Middle East & Africa Direct Oral Anticoagulant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Direct Oral Anticoagulant Sales Forecast by Type (2023-2028) & (MT)
Table 87. Global Direct Oral Anticoagulant Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Direct Oral Anticoagulant Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Direct Oral Anticoagulant Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Direct Oral Anticoagulant Sales Forecast by Application (2023-2028) & (MT)
Table 91. Global Direct Oral Anticoagulant Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Direct Oral Anticoagulant Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Direct Oral Anticoagulant Revenue Market Share Forecast by Application (2023-2028)
Table 94. Bristol-Meyers Squibb Co Basic Information, Direct Oral Anticoagulant Manufacturing Base, Sales Area and Its Competitors
Table 95. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product Offered
Table 96. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 97. Bristol-Meyers Squibb Co Main Business
Table 98. Bristol-Meyers Squibb Co Latest Developments
Table 99. Pfizer Inc. Basic Information, Direct Oral Anticoagulant Manufacturing Base, Sales Area and Its Competitors
Table 100. Pfizer Inc. Direct Oral Anticoagulant Product Offered
Table 101. Pfizer Inc. Direct Oral Anticoagulant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 102. Pfizer Inc. Main Business
Table 103. Pfizer Inc. Latest Developments
Table 104. Boehringer Ingelheim Pharmaceuticals, Inc Basic Information, Direct Oral Anticoagulant Manufacturing Base, Sales Area and Its Competitors
Table 105. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product Offered
Table 106. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 107. Boehringer Ingelheim Pharmaceuticals, Inc Main Business
Table 108. Boehringer Ingelheim Pharmaceuticals, Inc Latest Developments
Table 109. Janssen Pharmaceuticals, Inc. Basic Information, Direct Oral Anticoagulant Manufacturing Base, Sales Area and Its Competitors
Table 110. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product Offered
Table 111. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 112. Janssen Pharmaceuticals, Inc. Main Business
Table 113. Janssen Pharmaceuticals, Inc. Latest Developments
Table 114. Bayer AG Basic Information, Direct Oral Anticoagulant Manufacturing Base, Sales Area and Its Competitors
Table 115. Bayer AG Direct Oral Anticoagulant Product Offered
Table 116. Bayer AG Direct Oral Anticoagulant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 117. Bayer AG Main Business
Table 118. Bayer AG Latest Developments
Table 119. Teva Pharmaceutical Industries Ltd Basic Information, Direct Oral Anticoagulant Manufacturing Base, Sales Area and Its Competitors
Table 120. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product Offered
Table 121. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 122. Teva Pharmaceutical Industries Ltd Main Business
Table 123. Teva Pharmaceutical Industries Ltd Latest Developments
Table 124. Pab Organics Private Limited Basic Information, Direct Oral Anticoagulant Manufacturing Base, Sales Area and Its Competitors
Table 125. Pab Organics Private Limited Direct Oral Anticoagulant Product Offered
Table 126. Pab Organics Private Limited Direct Oral Anticoagulant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 127. Pab Organics Private Limited Main Business
Table 128. Pab Organics Private Limited Latest Developments
Table 129. Daiichi Sankyo Company, Limited Basic Information, Direct Oral Anticoagulant Manufacturing Base, Sales Area and Its Competitors
Table 130. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product Offered
Table 131. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 132. Daiichi Sankyo Company, Limited Main Business
Table 133. Daiichi Sankyo Company, Limited Latest Developments
List of Figures
Figure 1. Picture of Direct Oral Anticoagulant
Figure 2. Direct Oral Anticoagulant Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Direct Oral Anticoagulant Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Direct Oral Anticoagulant Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Direct Oral Anticoagulant Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Apixaban
Figure 10. Product Picture of Dabigatran
Figure 11. Product Picture of Rivaroxaban
Figure 12. Product Picture of Edoxaban
Figure 13. Global Direct Oral Anticoagulant Sales Market Share by Type in 2021
Figure 14. Global Direct Oral Anticoagulant Revenue Market Share by Type (2017-2022)
Figure 15. Direct Oral Anticoagulant Consumed in Hospitals Pharmacies
Figure 16. Global Direct Oral Anticoagulant Market: Hospitals Pharmacies (2017-2022) & (MT)
Figure 17. Direct Oral Anticoagulant Consumed in Drug Stores
Figure 18. Global Direct Oral Anticoagulant Market: Drug Stores (2017-2022) & (MT)
Figure 19. Direct Oral Anticoagulant Consumed in Online Pharmacies
Figure 20. Global Direct Oral Anticoagulant Market: Online Pharmacies (2017-2022) & (MT)
Figure 21. Global Direct Oral Anticoagulant Sales Market Share by Application (2017-2022)
Figure 22. Global Direct Oral Anticoagulant Revenue Market Share by Application in 2021
Figure 23. Direct Oral Anticoagulant Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Direct Oral Anticoagulant Revenue Market Share by Company in 2021
Figure 25. Global Direct Oral Anticoagulant Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Direct Oral Anticoagulant Revenue Market Share by Geographic Region in 2021
Figure 27. Global Direct Oral Anticoagulant Sales Market Share by Region (2017-2022)
Figure 28. Global Direct Oral Anticoagulant Revenue Market Share by Country/Region in 2021
Figure 29. Americas Direct Oral Anticoagulant Sales 2017-2022 (MT)
Figure 30. Americas Direct Oral Anticoagulant Revenue 2017-2022 ($ Millions)
Figure 31. APAC Direct Oral Anticoagulant Sales 2017-2022 (MT)
Figure 32. APAC Direct Oral Anticoagulant Revenue 2017-2022 ($ Millions)
Figure 33. Europe Direct Oral Anticoagulant Sales 2017-2022 (MT)
Figure 34. Europe Direct Oral Anticoagulant Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Direct Oral Anticoagulant Sales 2017-2022 (MT)
Figure 36. Middle East & Africa Direct Oral Anticoagulant Revenue 2017-2022 ($ Millions)
Figure 37. Americas Direct Oral Anticoagulant Sales Market Share by Country in 2021
Figure 38. Americas Direct Oral Anticoagulant Revenue Market Share by Country in 2021
Figure 39. United States Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Direct Oral Anticoagulant Sales Market Share by Region in 2021
Figure 44. APAC Direct Oral Anticoagulant Revenue Market Share by Regions in 2021
Figure 45. China Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Direct Oral Anticoagulant Sales Market Share by Country in 2021
Figure 52. Europe Direct Oral Anticoagulant Revenue Market Share by Country in 2021
Figure 53. Germany Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Direct Oral Anticoagulant Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Direct Oral Anticoagulant Revenue Market Share by Country in 2021
Figure 60. Egypt Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Direct Oral Anticoagulant Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Direct Oral Anticoagulant in 2021
Figure 66. Manufacturing Process Analysis of Direct Oral Anticoagulant
Figure 67. Industry Chain Structure of Direct Oral Anticoagulant
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...